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Background: Carotid intraplaque hemorrhage is a marker of atheroma instability. Noninvasive assessment of bleeding can
be performed by high-resolution magnetic resonance imaging (MRI), but its association with inflammatory markers has
not been clearly demonstrated.
Methods: We evaluated consecutive carotid endarterectomy patients that underwent high-resolution MRI, independent
evaluation of neurologic symptoms, C-reactive protein measurement, and histologic analysis. Intraplaque hemorrhage
was determined by the presence of a hyperintense MRI signal (T1-weighted sequence).
Results: The study included 70 predominantly male (66%) and hypertensive (89%) patients (89%) aged 66  9 years old.
MR angiography identified 15 patients (21.5%) with stenosis between 50% and 69%, 15 (21.5%) with stenosis between
70% and 90%, and 40 (57%) with stenosis >90%. High-resolution MRI depicted a hyperintense signal suggestive of
intraplaque bleeding in 45 subjects (64%). All patients who had had transient ischemic attacks >90 days before the
surgery showed a hyperintense signal on MRI (P .007). Age, gender, traditional cardiovascular risk factors, and history
of myocardial infarction or peripheral arterial disease were similar in patients with or without signs of intraplaque
bleeding on MRI. There was excellent agreement between acute or recent hemorrhage on histologic and MRI findings (
coefficient, 0.91; 95% confidence interval, 0.81 to 1.00). Only one of 45 patients (2%) with a hyperintense signal on MRI
did not have acute or recent hemorrhage in the histologic analysis (P < .001). High-sensitivity C-reactive protein levels
were similar for different degrees of carotid stenosis as assessed by MR angiography, but they were significantly higher in
clinically unstable patients (P  .006) and in those with a positive hyperintense MRI signal (P  .01). In an aggregated
analysis of neurologic symptoms and MRI findings, we found a progressive increase of high-sensitivity C-reactive protein
levels (P  .02).
Conclusions: Intraplaque hemorrhage evaluated by MRI identified neurologically unstable patients with increased levels
of high-sensitivity C-reactive protein regardless of the degree of carotid stenosis. ( J Vasc Surg 2007;46:1130-7.)Cerebral vascular disease is a major cause of morbidity
and mortality in the adult population.1,2 Atherothrombosis
of the carotid bifurcation is responsible for approximately
30% of cerebral ischemic episodes, and carotid endarterec-
tomy is considered the treatment of choice for selected
patients.3 Although current indications for carotid endar-
terectomy are based on luminal stenosis, some clinical and
histopathologic evidence indicates that acute vascular
events occur mostly due to the instability of vulnerable
plaques.4,5 Indeed, atheroma vulnerability is not directly
related to the occlusive nature of the atheroma, depending
instead on other factors, such as local and systemic immu-
noinflammatory responses, structural imbalance of the ex-
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1130tracellular matrix components, intraplaque hemorrhage,
rupture of the fibrous cap, and thrombogenesis.6-8
High-sensitivity C-reactive protein (hs-CRP) is the
prototype serum inflammatory marker of coronary and
carotid artery atherosclerotic disease.9-11 Although no def-
inite association has been found between hs-CRP and
initial carotid atherosclerosis, as assessed by intimal-medial
thickness,12 high levels of hs-CRP have been associated
with the presence of extracranial atherosclerotic disease13
and the prediction of cerebral ischemic events in the general
population.14 The role of hs-CRP on the events that lead to
clinical instability of carotid atherosclerotic disease, how-
ever, is much less clear.15
Detailed in vivo morphologic characterization of the
carotid atheroma has greatly improved in the last few years,
particularly because of advances in noninvasive imaging
techniques.16 High-resolution magnetic resonance imag-
ing (MRI) allows in vivo imaging of areas of hemorrhage in
the medial layer of carotid artery plaques by the identifica-
tion of segments with intense brightness (described as a
hyperintense signal) using specific MRI protocols.17,18 Al-
though the hyperintense signal on carotid MRI has an
adequate correlation with clinical and histologic find-
ings,19,20 its association with serum inflammatory markers
has not yet been completely clarified.
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carotid endarterectomy patients who underwent in vivo
morphologic evaluation of the carotid atheroma by high-
resolution MRI, independent assessment of neurologic
symptoms, measurement of hs-CRP levels, and histopatho-
logic analysis of the plaque. Our main objective was to
evaluate potential associations between the occurrence of
intraplaque hemorrhage assessed by MRI and other clinical
markers of carotid vulnerability.
METHODS
Patients. The present study enrolled patients with def-
inite carotid atherosclerotic disease and internationally ac-
cepted, guideline-based criteria for carotid endarterect-
omy.21,22 Patients were selected between December 2004
and December 2005, at the Cardiovascular Surgery Divi-
sion of the São Lucas Hospital of the Pontifical Catholic
University of Rio Grande do Sul, Brazil. Patients with
known infectious or autoimmune diseases, and those who
were unable to undergo MRI or whose atherosclerotic
plaque was considered to be unsuitable for histologic anal-
ysis (n  2) were not included in the present study. Also
excluded were patients with conditions might increase hs-
CRP levels, including severe peripheral arterial disease,
including pain at rest, ischemic cutaneous lesions, or gan-
grene, and those with acute coronary syndromes who had
undergone surgical or percutaneous interventions 90
days. The present protocol was approved by the Ethics
Committee of our institution, and all patients signed a
written informed consent form before enrollment.
Clinical characterization. All patients were classified
according to the presence and evolution of neurologic
symptoms, as assessed by an experienced neurologist
(M. F.) who was unaware of MRI data or other clinical
variables. Patients were classified as (1) unstable (or re-
cently symptomatic), defined as the presence of ipsilateral
hemispheric symptoms in patients in whom plaques were
removed 90 days of the event, or (2) stable (asymptom-
atic or remotely symptomatic), defined as patients with no
ipsilateral neurologic symptoms or with ipsilateral hemi-
spheric symptoms, but with endarterectomy performed
90 days after the event.
Magnetic resonance imaging. All MRI exams were
performed on a Siemens Magneton Vision Plus apparatus
(Siemens Inc, Erlangen, Germany). The MRI protocol
included two different contrast-weighted images: time of
flight (TOF) to estimate level of angiographic stenosis and
T1-weighted (T1W) sequence to access intraplaque hem-
orrhage, using the same image window acquisition.
Magnetic resonance angiography (MRA) was per-
formed by the usual technique, in three-dimensional (3D)
TOF pulse sequences, corresponding to the noncontrast
phase, and gradient 3D Turboflash, related to the contrast
phase (intravenous gadolinium). Luminal stenosis was de-
termined according to North American Symptomatic Ca-
rotid Endarterectomy Trial (NASCET) criteria23 and eval-
uated by the ratio between the smallest diameter of the
narrowed segment and the largest diameter of the internalcarotid artery, distal to the lesion. The graduation of steno-
sis was adapted from Nederkoorn et al,24 divided into three
categories: 50% to 69% stenosis, 70% to 90% stenosis, and
stenosis 90%.
The technique used to detect areas of hemorrhage was
similar to the protocol described by Moody et al,17 with the
purpose of identifying the presence of methemoglobin in
the extracellular matrix. We used a 3D magnetization-
prepared rapid gradient-echo pulse sequence, with 10.3
milliseconds of repetition time, 4milliseconds of echo time,
and 1000 milliseconds of delay time; flip angle, 15°; one
acquisition. Fat suppression was used for T1W images to
reduce signals from subcutaneous tissue. This combination
produced signal amplification in T1W in areas containing
recent thrombus or hemorrhage, identified by the hyperin-
tense signal (carotid high signal). Whenever the brightness
wasmore intense than in adjacent soft tissues, the signal was
classified as positive for acute or recent hemorrhage. Images
were obtained with a 30 30 cm2 field of view, matrix size,
256; and 1.07-mm slice thickness.
MRIs were interpreted by two experienced blinded
reviewers (J. R. H. and M. B. M.). The highest percentage
of stenosis prevailed in the case of disagreement between
the reviewers. Plaque length was measured and the proxi-
mal and distal margins were defined for comparisons with
histology findings.
Serum immunoinflammatory markers. In the oper-
ating room, before anesthetic induction, 20 mL of blood
was drawn from a peripheral vein and immediately pro-
cessed. The level of hs-CRP was measured according to a
nephelometric method by the Behring CardioPhase assay
(Behring Inc, Marburg, Germany), in which monoclonal
antibodies to human CRP were used in a cooled serum
aliquot, as previously described.25
Surgical technique. All patients were operated on by
the same surgeon (L. C. A.) under general anesthesia, with
orotracheal intubation and monitoring of mean arterial
pressure. Dissection of the carotid bifurcation was per-
formed according to the usual technique, avoiding hemo-
stasis by compression to limit embolization or disarrange-
ment of the plaque architecture. After infusion of
intravenous heparin (1.0 mg/kg), an anterior longitudinal
arteriotomy was performed, long enough to reach the
margin of the normal artery wall, 1.0 cm cranially and
caudally to the lesion. The atheroma was removed by
detachment and immediately stored in a 10% formol solu-
tion. After removal of plaque debris, anticoagulation was
reversed with intravenous protamine (1.0 mg/kg).
Histologic analysis. During surgery, every effort was
made to avoid disruption of the plaque anatomy and to
identify both the posterior-anterior and proximal-cranial
references for subsequent comparison with MRI. Thus,
before infusion of formol solution, the posterior and cranial
surfaces of plaque specimens were dyed to define spatial
markers for later comparisons to MRI findings, as recom-
mended by Lovett et al.26 After decalcification and inclu-
sion in paraffin block, 10-m samples were sectioned at
every 3.0 mm of the histologic block and stained with
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Analysis of histopathology was performed by an experi-
enced pathologist (A. A. M.) who was unaware of clinical
and laboratory data.
Characterization of intraplaque hemorrhage was adapted
from Lusby et al.27 Acute hemorrhage (1 week) was defined
by the presence of intact erythrocytes or as intracellular met-
hemoglobin, identified as an orange-reddish coloring associ-
ated with focal macrophage activity. Recent hemorrhage
(between 1 and 6 weeks) was characterized as the presence
of lysed erythrocytes with extracellular methemoglobin or
hemorrhage fragments dyed as a brownish red color, asso-
ciated with agglomeration of macrophages with hemosid-
erin and giant cells. Late hemorrhage (6 weeks) was
classified according to the presence of amorphous material
fragments, with hemosiderin dyed blue and bright pink
with hematoxylin and eosin stain associated with calcifica-
tion. The lack of these findings was characterized as an
absence of hemorrhage.
For statistical analysis, acute and recent bleeding was
aggregated and defined as current intraplaque hemorrhage.
Late or absent bleeding was also aggregated and defined as
old or absent intraplaque hemorrhage. Fibrous cap was
classified semi-quantitatively according to Hatsukami et
al28 as normal whenever its thickness was  0.25 m; or
thin whenever its thickness was 0.25 m at any point of
analysis.
Correlation between magnetic resonance findings
and histology. The protocol to match MRI images and
histology sections has been described by Cappendijk et al.29
Slices 4-m thick were cut every 3.0 mm from every plaque
cross section, and the corresponding points on the angio-
graphic MRI film were marked in coronal axis. MRI images
were then reconstructed in axial axis, in the sequence for
evaluation of the hyperintense signal and recorded on
radiology films, with the same magnification window. Each
MRI film was compared with the corresponding histologic
cut, with the same spatial orientation in the anteroposterior
and craniocaudal axes.
Statistical analysis. Continuous variables with normal
distribution were expressed as average standard deviation
and compared using the Student t test or analysis of vari-
ance (ANOVA). The hs-CRP results underwent logarith-
mic transformation because they did not present normal
distribution and were also compared by using the Student
t test or ANOVA, with post hoc analysis when appropriate.
Categoric variables were expressed as frequencies and per-
centages. For comparisons between different groups, the 2
test or the Fisher exact test were used. To assess the
agreement between different methods of evaluation of the
atherosclerotic plaque, we calculated the  coefficient. A
bicaudal P  0.05 was considered statistically significant.
Analyses were performed using SAS 8.0 software (SAS
Institute, Cary, NC).
RESULTS
Patient characteristics. The study comprised 72 pa-
tients who underwent carotid endarterectomy. Two pa-tients were excluded because their carotid plaques could
not be adequately dissected during surgery due to fragmen-
tation, impeding the subsequent alignment with MRI find-
ings. Patients were predominantly male (66%) and hyper-
tensive (89%) and had a mean age of 66  9 years. As
expected, several patients also reported a history of con-
comitant coronary arterial disease: 26% had symptoms of
angina pectoris and 19% had sustained a previous myocar-
dial infarction. A history (90 days before the procedure)
of a cerebral vascular attack (CVA) was found in 34% of
patients and a transient ischemic attack in 16%. Statins were
used by 69 patients (99%), and 46 (66%) also used the
platelet-inhibiting drugs aspirin, ticlopidine, or clopi-
dogrel. Other clinical characteristics and comorbidities are
described in the Table.
According to the independent neurologic evaluation,
28 patients (40%) were considered stable, of whom 19
(27%) were asymptomatic, and 9 (13%) had experienced
symptoms of ipsilateral ischemic stroke 90 days before
carotid endarterectomy; whereas 42 (60%) were considered
unstable (12 recent ipsilateral strokes and 30 TIAs). The
average time between the occurrence of symptoms and
collection of the atheroma in the clinically unstable group
was 22  11 days (range, 4 to 45 days). Most patients
(79%) reported symptoms 30 days before surgery.
Magnetic resonance findings. MRAwith gadolinium
identified 15 patients (21.5%) with stenosis of 50% to 69%,
15 (21.5%) with 70% to 90% stenosis, and 40 (57%) with
90% stenosis. In the asymptomatic patients, 14 (16%) had
luminal stenosis70%, and only five (7%) were classified by
MRA as having a 50% to 59% carotid stenosis. In the T1W
sequence, a hyperintense signal suggesting intraplaque
hemorrhage was identified in 45 patients (64%). Age, gen-
der, traditional cardiovascular risk factors, and history of
previous myocardial infarction or peripheral arterial disease
were similar in patients with or without signs of intraplaque
bleeding on MRI (Table). Of interest was that all patients
who had a TIA 90 days before the surgery showed the
hyperintense signal (P  .007), which was found in 17 of
24 patients who sustained a previous stroke. We also ob-
served a significant association between neurologic symp-
toms and MRI findings: 98% of the unstable cases had a
positive hyperintense signal on MRI, but only 14% of the
stable patients showed the same finding (P  .001, Fig 1).
There was an excellent agreement between the assessments
of both radiologists. There was concordance in the assess-
ment of the hyperintense MRI signal in all cases, whereas
the  coefficient was 0.95 in the evaluation of angiographic
stenosis.
Histopathologic findings and correlation with
magnetic resonance imaging. Fibrous cap thickness was
0.25 m in 46 patients (66%) and 0.25 m in 24
(34%). Intraplaque hemorrhage was described in the histo-
logic analysis as acute in 26 patients (37%), recent in 19
(27%), old in 2 (3%), and absent in 23 (33%). There was
excellent agreement between the histologic finding of acute
or recent hemorrhage and the MRI findings ( coefficient,
0.91; 95% confidence interval, 0.81 to 1.00). Only one of
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have acute or recent hemorrhage in the histologic analysis;
conversely, only two of the 25 patients (8%) without a
hyperintense MRI signal had acute or recent hemorrhage
on pathology. Sensitivity and specificity of a positive MRI
to detect intraplaque hemorrhage was 96%. However, no
significant association between the presence of a positive
hyperintense signal on MRI and fibrous cap thickness (P
.38) or carotid luminal stenosis (P  .92, Fig 2) was found.
Fig 3 and Fig 4 depict examples of correlations between
Fig 1. Association between the presence of hyperintense signal
on high-resolution magnetic resonance imaging (MRI) and neu-
rologic symptoms as evaluated by an independent neurologist
unaware of MRI findings.
Table. Clinical characteristics
Characteristic* All, N  70
Age, y 66  9.3
Male, No. (%) 46 (66)
Active smoking, No. (%) 19 (27)
Hypertension, No. (%) 62 (89)
Diabetes, No. (%) 32 (46)
Obesity, No. (%) 24 (34)
Stable angina, No. (%) 18 (26)
Previous MI, No. (%) 13 (19)
Previous CABG, No. (%) 14 (20)
PAD, No. (%) 33 (47)
Arial fibrillation, No. (%) 3 (4)
Blood pressure, mm Hg
Systolic 133  20
Diastolic 79  12
Cholesterol, mg/dL
Total 174  50
LDL 103  47
HDL 42  18
Triglycerides, mg/dL 185  11
MRI, Magnetic resonance imaging; MI, myocardial infarction; CABG, cor
disease; LDL, low-density lipoprotein; HDL, high density lipoprotein.
*Continuous data are presented as mean  SD.MRI and histologic data.As expected, excellent concordance between neuro-
logic symptoms and histopathologic findings was also ob-
served (2 p  .0001). Acute or recent hemorrhage in the
histologic analysis was identified in 18% of the stable group
(5 of 28) and in 98% of unstable patients (41of 42).
C-reactive protein. Mean hs-CRP values were 1.2 
1.5 mg/L in the 70 cases studied. The hs-CRP levels were
essentially identical for the different degrees of carotid
stenosis assessed by MRA (Fig 5, A), but they were signif-
icant higher in clinically unstable patients compared with
neurologically stable patients (1.54  1.7 vs 0.67  0.8
mg/L, respectively; P  .006). Similarly, those patients
who showed a positive hyperintense MRI signal also had
Fig 2. Absence of association between the presence of hyperin-
tense signal on high-resolution magnetic resonance imaging
(MRI) and different degrees of angiographic stenosis.
Hyper-intense signal on MRI
Pith, n  45 Without, n  25
65  8.9 66  9.3 .88
31 (69) 15 (60) .45
10 (22) 9 (36) .46
42 (93) 20 (80) .09
20 (44) 12 (48) .77
16 (36) 8 (32) .76
12 (27) 6 (24) .81
8 (18) 5 (20) .82
10 (22) 4 (16) .53
23 (51) 10 (40) .37
3 (7) 0 .19
134  19 133  27 .85
79  12 80  11 .81
171  56 179  38 .55
100  52 109  37 .47
44  22 38  7 .08
193  117 172  109 .47
artery bypass graft; TIA, transient ischemic attack; PAD, peripheral arteryW
onaryhigher hs-CRP levels (1.47 1.7 vs 0.7 0.8 mg/L; P
emo
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teristics andMRI findings, a progressive increase of hs-CRP
levels was observed (P  .02, Fig 5, B).
Levels of hs-CRP doubled in patients with a hyperin-
tense MRI signal. Using the highest quartile of this marker
(hs-CRP 1.58 mg/L) as the cutoff level, we observed a
specificity of 96% and a sensitivity of 37% for the presence of
Fig 3. A, Representative example of high-resolution m
signal (white arrows) on sagittal and (B) axial views. C
from the same patient show the absence of intraplaque h
Fig 4. A, Representative example of high-resolution m
arrows) on sagittal and (B) axial views. C, Histologic
recognized as extracellular and intracellular metahemogl
coloring).intraplaque hemorrhage on histology.DISCUSSION
Carotid bifurcation atheroma causes 20% to 30% of
CVAs and it is well established that the degree of angio-
graphic stenosis is the major determinant of surgical inter-
vention. However, a growing body of evidence clearly
demonstrates that carotid plaque vulnerability is not di-
etic resonance imaging shows absence of hyperintense
, Histologic findings (hematoxylin and eosin staining)
rrhage.
tic resonance imaging shows hyperintense signal (white
gs of intraplaque hemorrhage from the same patient,
on (D) hematoxylin and eosin staining (reddish-orangeagn
and Dagne
findin
obinrectly influenced by the obstructive nature of the plaque
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and biochemical disarrangements of the atheroma,6,8,30,31
particularly involving local and systemic immunoinflamma-
tory processes. Our data indicate that noninvasive assess-
ment of carotid atherosclerotic plaques by high-resolution
MRI can adequately identify important morphologic and
structural aspects of the atheroma, in particular the pres-
ence of intraplaque hemorrhage. Furthermore, we showed
that this finding is associated with increases in hs-CRP
levels and instability of neurologic symptoms.
Previous studies have assessed the association of hs-
CRP levels and the presence of cerebral vascular disease.
Data from the Framingham study indicate that men in the
highest quartile of hs-CRP doubled their risk of ischemic
stroke and transient ischemic attacks, whereas women tri-
pled their risk.14 Wang et al32,33 demonstrated that the
Fig 5. A, High-sensitivity C-reactive protein (hs-CRP) levels ac-
cording to different degrees of angiographic stenosis. B, Levels of
hs-CRP according to the presence of stable or unstable neurologic
symptoms and the presence of hyperintense signal on high-
resolution magnetic resonance imaging.development of plaques in the internal carotid artery, re-gardless of the presence of clinical disease, wasmore evident
in the highest quartile of hs-CRP.33 In addition, the asso-
ciation of hs-CRP, carotid intimal-medial thickness, and
CVA risk was prospectively assessed in 5417 elderly patients
in the Cardiovascular Health Study.34 A strong positive
correlation between hs-CRP levels and CVA risk was found
in the highest tertile of thickening.
In the present study, we evaluated hs-CRP levels in pa-
tients undergoing carotid endarterectomy. We used pre-
defined criteria of clinical instability. Our results suggest a
direct relationship between hs-CRP and clinical instability and
demonstrate for the first time, to the best of our knowledge, a
significant association between hs-CRP levels and MRI char-
acteristics of vulnerability. Our data corroborate results of
Garcia et al,15 who investigated the association between hs-
CRP levels and histologic and immunocytologic aspects of
carotid plaques. The levels of Hs-CRP were significantly
higher in those cases classified as histologically unstable, dem-
onstrating a positive correlation with macrophage infiltration
and T lymphocytes in the plaque.15
In this scenario, our findings contribute to the under-
standing of the complex interplay of events that take place
when a carotid plaque becomes unstable, potentially lead-
ing to the development of acute neurologic symptoms. It is
reasonable to speculate that among several other factors,
the physiopathologic basis for these processes involves both
intraplaque hemorrhage and inflammatory responses. We
demonstrate here that these processes are interconnected
and may identify patients at greater risk of neurologic
events.
Recent investigations have attempted to identify in vivo
morphologic characteristics of the vulnerable carotid ath-
eroma. Several studies correlating different imaging tech-
niques and histologic analyses were used to validate these
techniques. The methodologic quality of these investiga-
tions was recently questioned in a systematic review of 73
studies in which only 23% adequately assessed the repro-
ducibility of image acquisition and in which the histologic
methods were comparable for only 12%.
Lovett et al26 suggest strict recommendations in the
preparation of histologic sections, such as the use of repre-
sentative samples with a similar number of symptomatic
and asymptomatic cases, detailed registration of the tem-
poral relationship with symptoms, image acquisition with-
out significant delay in relation to histologic analysis, care-
ful spatial orientation of blocks, maximum 3-mm cuts, and
blinded reading of both results.26 We attempted to comply
with most of these strict quality criteria in the study design,
although patient enrollment was not perfectly balanced
between symptomatic and asymptomatic subjects. None-
theless, our study demonstrated an excellent agreement
between the presence of a hyperintense signal on high-
resolution MRI and acute or recent intraplaque hemor-
rhage. Moody et al17 found a similar prevalence of carotid
intraplaque bleeding by high-resolution MRI in symptom-
atic patients but observed a lower histologic concordance.
Other recent studies have analyzed clinical instability
and plaque morphology. Saam et al35 evaluated 23 patients
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and demonstrated a significant correlation between symp-
tomatic plaques and several features of fibrous cap structure
and intraplaque hemorrhage compared with contralateral
asymptomatic plaques in the same patients. Takaya et al36
reported the evolution of 154 consecutive subjects, dem-
onstrating that arteries with thinned or ruptured fibrous
caps and intraplaque hemorrhage by MRI were associated
with the occurrence of subsequent cerebrovascular events,
suggesting the need for larger, multicenter studies to char-
acterize the clinical role of plaque features for the predic-
tion of subsequent ischemic events.
Our results are also in agreement with a recent study by
Chu et al19 that added the weighted sequence in T2 to
distinguish fresh, recent, or old hemorrhage. These authors
observed a moderate to strong agreement between MRI
and histologic findings ( coefficient, 0.7). Although we
were unable to perform a detailed structural analysis of the
fibrous cap by MRI, the presence of a hyperintense signal
was not associated with a semi-quantitative evaluation of
fibrous cap histology. This finding may indicate that other
mechanisms not solely related to fibrous cap structure may
be involved in the development of neurologic events. In
this scenario, it is plausible to speculate that inflammatory
processes mediated or identified by hs-CRP may be in-
volved.
The absence of a correlation between a highMRI signal
and luminal stenosis evaluated by MRA concurs with cur-
rent evidence indicating that the phenomena of positive
remodeling and eccentricity are dominant in relation to the
occlusive character of the atheroma in the genesis of ische-
mic ipsilateral strokes. Novel markers of carotid atheroscle-
rotic instability capable of identifying inflammatory or pro-
thrombotic activity inside the plaque, as shown in our
study, have been recently suggested.16 High-resolution
MRI has emerged as the imaging technique with the best
technical profile to accurately recognize such findings.37
Some limitations related to our study design and anal-
yses must be considered. The assessment of other serum
markers, such as the CD40 ligand complex or leukocyte
myeloperoxidase activity, could potentially add important
information concerning local and systemic inflammatory
activity. Hs-CRP, however, is the inflammatorymarker that
has been most widely evaluated in clinical and pathologic
studies from both coronary and carotid arteries. We cannot
ensure that a perfect alignment (particularly in the submil-
limeter range) was obtained between the histologic analysis
and MRI imaging. This potential bias, however, does not
invalidate the overall excellent agreement observed be-
tween MRI findings and intraplaque hemorrhage. The
T1W sequence used in the current MRI protocol did not
allow specific evaluation of fibrous cap structure. Also, the
semi-quantitative analysis of fibrous cap thickness by histol-
ogy, as proposed by Hatsukami et al,28 may have limited
our assessment of the importance of fibrous cap structure.
Finally, our statistical power was not adequate to allow
stratified data analysis, particularly concerning histologic
risk features.CONCLUSION
Our results demonstrate that the presence of a hyper-
intense signal on high-resolution MRI of carotid arteries in
patients undergoing carotid endarterectomy is associated
with increased systemic inflammatory activity. This partic-
ular finding was not related to the degree of angiographic
stenosis or to fibrous cap thickness. These results, when
viewed in light of evidence from other related investiga-
tions, are consistent with the concept that luminal stenosis
in extracranial atherosclerotic disease, as in coronary vascu-
lar processes, is not an adequate marker of atheroma vul-
nerability. Contemporary scientific evidences suggest that
other structural, molecular, and biochemical characteristics
that participate in the atherosclerotic process deserve to be
prospectively assessed in future studies as potential predic-
tors for a timely indication of carotid endarterectomy.
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